The LIM domain protein Lmo2 binds to AF6, a translocation partner of the MLL oncogene

FEBS Lett. 2002 Jun 19;521(1-3):36-8. doi: 10.1016/s0014-5793(02)02814-4.

Abstract

The LIM only protein Lmo2 plays an important role in hematopoiesis and leukemogenesis. Lmo2 acts as a bridging molecule between components of hematopoietic gene regulatory protein complexes. We used the yeast two-hybrid system to identify novel Lmo2 interacting proteins and found that the AF6 protein binds to Lmo2. AF6 is a recurrent fusion partner of MLL, the human homolog of Drosophila trithorax chromatin remodeling protein that is involved in childhood leukemia and mixed lineage leukemia. Our data support the notion that recurrent fusion partners of chimeric MLL proteins recruit hematopoietic gene regulatory complexes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Animals
  • Cell Line
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism*
  • Drosophila Proteins*
  • Histone-Lysine N-Methyltransferase
  • Humans
  • Jurkat Cells
  • Kinesins / genetics
  • Kinesins / metabolism*
  • LIM Domain Proteins
  • Metalloproteins / genetics
  • Metalloproteins / metabolism*
  • Myeloid-Lymphoid Leukemia Protein
  • Myosins / genetics
  • Myosins / metabolism*
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / metabolism*
  • Proto-Oncogenes*
  • Quail
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Transcription Factors*

Substances

  • AFDN protein, human
  • Adaptor Proteins, Signal Transducing
  • DNA-Binding Proteins
  • Drosophila Proteins
  • KMT2A protein, human
  • LIM Domain Proteins
  • LMO2 protein, human
  • Metalloproteins
  • Proto-Oncogene Proteins
  • Recombinant Fusion Proteins
  • Transcription Factors
  • cno protein, Drosophila
  • Myeloid-Lymphoid Leukemia Protein
  • Histone-Lysine N-Methyltransferase
  • Myosins
  • Kinesins